Orchid Pharma Balance Sheet Health
Financial Health criteria checks 6/6
Orchid Pharma has a total shareholder equity of ₹11.1B and total debt of ₹1.5B, which brings its debt-to-equity ratio to 13.3%. Its total assets and total liabilities are ₹14.9B and ₹3.8B respectively. Orchid Pharma's EBIT is ₹886.6M making its interest coverage ratio 4.5. It has cash and short-term investments of ₹503.6M.
Key information
13.3%
Debt to equity ratio
₹1.47b
Debt
Interest coverage ratio | 4.5x |
Cash | ₹503.63m |
Equity | ₹11.08b |
Total liabilities | ₹3.84b |
Total assets | ₹14.92b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 524372's short term assets (₹5.0B) exceed its short term liabilities (₹2.4B).
Long Term Liabilities: 524372's short term assets (₹5.0B) exceed its long term liabilities (₹1.5B).
Debt to Equity History and Analysis
Debt Level: 524372's net debt to equity ratio (8.8%) is considered satisfactory.
Reducing Debt: 524372 had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Debt Coverage: 524372's debt is well covered by operating cash flow (70.8%).
Interest Coverage: 524372's interest payments on its debt are well covered by EBIT (4.5x coverage).